The Journal of Immunology, Vol 150, Issue 8 3161-3169, Copyright © 1993 by American Association of Immunologists

ARTICLES

CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling

PS Linsley, J Bradshaw, M Urnes, L Grosmaire and JA Ledbetter
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121.

Costimulatory molecules on the APC regulate T cell growth by providing signals that regulate responses to TCR occupancy. One such molecule is B7/BB-1, which triggers a T cell activation pathway by binding the CD28 and/or CTLA-4 cell-surface molecules. Expression and signaling activity of CD28 have been shown to increase after T cell activation by various polyclonal activators. Here we show that CD28 expression and signaling activity in activated T cells decrease after ligand binding to CD28. Stimulation of CD28 on PHA- or PMA-activated T cells by cross-linked mAb 9.3 or by co-culture with B7+ Chinese hamster ovary (CHO) cells caused a marked reduction of CD28 mRNA levels within 4 h. The decrease in CD28 mRNA was transient, and by 24 h of CD28 stimulation, CD28 mRNA was found at approximately initial levels. In contrast, CTLA-4 mRNA levels were usually up-regulated by CD28 triggering. Cell-surface expression of CD28, but not CD2 or CD3, decreased by 12 to 24 h after addition of B7+ CHO cells, but returned to initial levels or higher by 48 h. The ability of CD28 cross-linking on PMA-activated CD4+ cells to trigger calcium mobilization was also reduced by treatment with B7+ CHO cells, and remained reduced even after cell-surface expression of CD28 returned to normal levels. Thus, engagement of the CD28 receptor by its natural ligand B7/BB-1 leads to a transient down-regulation of CD28 synthesis and a prolonged unresponsiveness to CD28 signaling. This represents a novel mechanism for regulation of costimulatory signals delivered by interactions of CD28 with the B7/BB-1 counter receptor.

This article has been cited by other articles:

				J. R. Podojil and S. D. Miller Cross-Linking of CD80 on CD4+ T Cells Activates a Calcium-Dependent Signaling Pathway J. Immunol., January 15, 2009; 182(2): 766 - 773. [Abstract] [Full Text] [PDF]

				L. Strauss, C. Bergmann, M. J. Szczepanski, S. Lang, J. M. Kirkwood, and T. L. Whiteside Expression of ICOS on Human Melanoma-Infiltrating CD4+CD25highFoxp3+ T Regulatory Cells: Implications and Impact on Tumor-Mediated Immune Suppression J. Immunol., March 1, 2008; 180(5): 2967 - 2980. [Abstract] [Full Text] [PDF]

				W. K. Chiu, M. Fann, and N.-p. Weng Generation and Growth of CD28nullCD8+ Memory T Cells Mediated by IL-15 and Its Induced Cytokines J. Immunol., December 1, 2006; 177(11): 7802 - 7810. [Abstract] [Full Text] [PDF]

				G. J. de Bree, E. M.M. van Leeuwen, T. A. Out, H. M. Jansen, R. E. Jonkers, and R. A.W. van Lier Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung J. Exp. Med., November 21, 2005; 202(10): 1433 - 1442. [Abstract] [Full Text] [PDF]

				S. Iwamoto, M. Ishida, K. Takahashi, K. Takeda, and A. Miyazaki Lipopolysaccharide stimulation converts vigorously washed dendritic cells (DCs) to nonexhausted DCs expressing CD70 and evoking long-lasting type 1 T cell responses J. Leukoc. Biol., August 1, 2005; 78(2): 383 - 392. [Abstract] [Full Text] [PDF]

				N. L. Alves, F. A. Arosa, and R. A. W. van Lier IL-21 Sustains CD28 Expression on IL-15-Activated Human Naive CD8+ T Cells J. Immunol., July 15, 2005; 175(2): 755 - 762. [Abstract] [Full Text] [PDF]

				M. J. Boaz, A. Waters, S. Murad, P. J. Easterbrook, and A. Vyakarnam Presence of HIV-1 Gag-Specific IFN-{gamma}+IL-2+ and CD28+IL-2+ CD4 T Cell Responses Is Associated with Nonprogression in HIV-1 Infection J. Immunol., December 1, 2002; 169(11): 6376 - 6385. [Abstract] [Full Text] [PDF]

				J. L. Riley, M. Mao, S. Kobayashi, M. Biery, J. Burchard, G. Cavet, B. P. Gregson, C. H. June, and P. S. Linsley Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors PNAS, September 3, 2002; 99(18): 11790 - 11795. [Abstract] [Full Text] [PDF]

				T. Spies Induction of T cell alertness by bacterial colonization of intestinal epithelium PNAS, March 5, 2002; 99(5): 2584 - 2586. [Full Text] [PDF]

				E. Bryl, M. Gazda, J. Foerster, and J. M. Witkowski Age-related increase of frequency of a new, phenotypically distinct subpopulation of human peripheral blood T cells expressing lowered levels of CD4 Blood, August 15, 2001; 98(4): 1100 - 1107. [Abstract] [Full Text] [PDF]

				J. E. Nichols, J. A. Niles, and N. J. Roberts Jr. Human Lymphocyte Apoptosis after Exposure to Influenza A Virus J. Virol., July 1, 2001; 75(13): 5921 - 5929. [Abstract] [Full Text] [PDF]

				G. Boulougouris, J. D. McLeod, Y. I. Patel, C. N. Ellwood, L. S. K. Walker, and D. M. Sansom IL-2-Independent Activation and Proliferation in Human T Cells Induced by CD28 J. Immunol., August 15, 1999; 163(4): 1809 - 1816. [Abstract] [Full Text] [PDF]

				M. Labalette, E. Leteurtre, C. Thumerelle, C. Grutzmacher, B. Tourvieille, and J.-P. Dessaint Peripheral human CD8+CD28+T lymphocytes give rise to CD28–progeny, but IL-4 prevents loss of CD28 expression Int. Immunol., August 1, 1999; 11(8): 1327 - 1336. [Abstract] [Full Text] [PDF]

				R. Khattri, J. A. Auger, M. D. Griffin, A. H. Sharpe, and J. A. Bluestone Lymphoproliferative Disorder in CTLA-4 Knockout Mice Is Characterized by CD28-Regulated Activation of Th2 Responses J. Immunol., May 15, 1999; 162(10): 5784 - 5791. [Abstract] [Full Text] [PDF]

				B. Metzler, C. Burkhart, and D. C. Wraith Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo Int. Immunol., May 1, 1999; 11(5): 667 - 675. [Abstract] [Full Text] [PDF]

				E. Van Hoffen, D. F. Van Wichen, J. C. Leemans, R. A.J.F. Broekhuizen, A. H. Bruggink, M. De Boer, N. De Jonge, H. Kirkels, P. J. Slootweg, F. H.J. Gmelig-Meyling, et al. T Cell Apoptosis in Human Heart Allografts : Association with Lack of Co-Stimulation? Am. J. Pathol., December 1, 1998; 153(6): 1813 - 1824. [Abstract] [Full Text] [PDF]

				G. Boulougouris, J. D. McLeod, Y. I. Patel, C. N. Ellwood, L. S. K. Walker, and D. M. Sansom Positive and Negative Regulation of Human T Cell Activation Mediated by the CTLA-4/CD28 Ligand CD80 J. Immunol., October 15, 1998; 161(8): 3919 - 3924. [Abstract] [Full Text] [PDF]

				R. Siefken, S. Klein-He{beta}ling, E. Serfling, R. Kurrle, and R. Schwinzer A CD28-Associated Signaling Pathway Leading to Cytokine Gene Transcription and T Cell Proliferation Without TCR Engagement J. Immunol., August 15, 1998; 161(4): 1645 - 1651. [Abstract] [Full Text] [PDF]

				A. N. Vallejo, A. R. Nestel, M. Schirmer, C. M. Weyand, and J. J. Goronzy Aging-related Deficiency of CD28 Expression in CD4+ T Cells Is Associated with the Loss of Gene-specific Nuclear Factor Binding Activity J. Biol. Chem., April 3, 1998; 273(14): 8119 - 8129. [Abstract] [Full Text] [PDF]